Bossi G, Gerry AB, Paston SJ, Sutton DH, Hassan NJ, Jakobsen BK. Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells. Oncoimmunology. 2013;2:e26840.Bossi, G, Gerry, AB, Paston, SJ, Sutton, DH, Hassan, NJ and Jakobsen, BK (2013). Examining...
A1278–286 (pMAGE-A1278–286 peptide pulsed T2 cells) and U251 (HLA-A2+, MAGE-A1+) at an effector:target ratio of 40:1, and approximately 5% cytolysis against T2pHIV, A172 (HLA-A2−, MAGE-A1+), K562 and T2 cells without being pulsed with peptide at any effector:target ratio...
(HLA-A2+, MAGE-A1+) at an effector:target ratio of 40:1, and approximately 5% cytolysis against T2pHIV, A172 (HLA-A2-, MAGE-A1+), K562 and T2 cells without being pulsed with peptide at any effector:target ratio.The specific killing activity of the induced CTLs against T2pMAGE-A...
InductionofCytotoxicTLymphocytesSpecifictoMalignantGliomaUsingT2CellsPulsedwithHLA-A2-restrictedInterleukin-13Receptor~2Peptideinvitro 生物化学与生物物理学报(英文)XiaobingJIANGXiaolingLURu'enLIUFangchengZHANGHongyangZHAO
Generation of bcr2abl specific cytotoxic T2lymphocytes by using dendritic cells pulsed with bcr2abl (b3a2) peptide :its applica2 bility for donor leukocyte transfusions in marrow grafted CML patients. Leukemia ,1999 ,13 (2) :166～174